Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7
|
pubmed:dateCreated |
1996-8-13
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0009-9147
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
42
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
999-1000
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8674213-Anabolic Agents,
pubmed-meshheading:8674213-Doping in Sports,
pubmed-meshheading:8674213-Gas Chromatography-Mass Spectrometry,
pubmed-meshheading:8674213-Georgia,
pubmed-meshheading:8674213-Humans,
pubmed-meshheading:8674213-Sensitivity and Specificity,
pubmed-meshheading:8674213-Sports,
pubmed-meshheading:8674213-Substance Abuse Detection
|
pubmed:year |
1996
|
pubmed:articleTitle |
Anabolic steroids, athletic drug testing, and the Olympic Games.
|
pubmed:publicationType |
Editorial,
Comment
|